Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our March issue:
FEATURES
Cover Story
 23andMe's Double Play: Making Science and Patients Partners
Casey McDonald
Pharm Exec's Casey McDonald profiles patient DNA partnering advocate 23andMe, which recently struck data deals with a pair of big Pharmas, thrusting the debate over personal genomics and patient treatment back into high gear.
Biotech
Behind the Boom in Biotech
William Looney
On the margins of January's annual JP Morgan investorfest, Pharm Exec convened a roundtable discussion with nine company aspirants for leadership in the hard science of small biotech.
Emerging Markets
 BioScience Bounty: Africa's Emerging Geography of Ideas
William Looney
Pfizer recently hosted a delegation of start-up entrepreneurs and R&D “incubator” executives with the aim to identify actions to break the logjams around great science through a sustainable network of private-sector bioscience enterprises — particularly in emerging market countries like South Africa, where useful precedents exist on delivering health innovations at lower cost to society
Sales
 Tomorrow's Selling Strategy: Test and Invest
 Rick Edmunds, Rolf Fricker, Stephan Danner, Nelia Padilla
 A new PwC survey reveals a strong need to fully embrace alternative commercial methods—not in a blind frenzy but through careful evaluation of which new sales strategies have true innovative potential.
ALSO IN THIS ISSUE
 Is There Gold in the DNA Selfie?
William Looney
Pharma jumps on board personal genomics train—at least for test drive—but will journey ultimately help transform treatment or stall out as just another fad?

 Pharma's Love Affair with Buzzwords
Timothy White
How pharma can finally put true meaning behind its juiced-up jargon and turn the bluster into reality.

Have Your Eggs, and Your Statin (and Your PCSK9 inhibitor too?)
Casey McDonald
The cholesterol-fighting market is back with a vengeance; plenty of complications in store.
WEBCASTS
New expensive treatments for hepatitis C infection: have US payers reached a tipping point?
Establishing Processes and Controls to Ensure an Inspection-ready TMF Every Day
Engineer Your Business to Win in the Mobile Selling Moment
Download the
issue:
image

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.
Twitter LinkedIn